Submit Content
Sponsored in Part By
Sponsored
Esophageal Cancer - Multimodality Therapy
Thoracic
Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs
By Mark Ferguson
Nov. 11, 2014
0
Thoracic
Impact of Neoadjuvant Chemoradiotherapy on Postoperative Outcomes After Esophageal Cancer Resection: Results of a European Multicenter Study
By Mark Ferguson
Oct. 8, 2014
0
Thoracic
Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer
By Mark Ferguson
Oct. 8, 2014
0
Thoracic
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
By Mark Ferguson
Sep. 25, 2014
0
Thoracic
Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer
By Mark Ferguson
Sep. 16, 2014
0
Esophagus
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
By Mark Ferguson
Aug. 9, 2014
0
Thoracic
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
By Mark Ferguson
Jul. 29, 2014
0
Esophagus
Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer
By Mark Ferguson
Jul. 28, 2014
0
Thoracic
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
By Mark Ferguson
Jul. 1, 2014
0
Thoracic
A Systematic Review of the Predictive Value of 18FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification
By Mark Ferguson
May. 27, 2014
0
1 2

Log In

New to CTSNet? Sign Up

Forgot Password